Qu Biologics invited to present at US National Cancer Institute (NCI) Conference
12. Juli 2017 17:06 ET
|
Qu Biologics
VANCOUVER, British Columbia, July 12, 2017 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a unique platform of immunotherapies...